Showing 15 posts of 27 posts found.


EU rules may be stifling Britain’s biotech industry

November 19, 2018
Sales and Marketing EU, biotech, britain, funding, grants, industry

EU rules are stifling Britain’s biotech industry, according to companies who talked to British newspaper The Daily Telegraph. The newspaper …

Health innovation system is broken and failing patients, new report argues

October 15, 2018
Sales and Marketing IP, industry, intellectual property, priofit, research

The pharmaceutical industry is incentivised to set high prices and deliver short-term returns to shareholders, rather than focusing on riskier, …


Sanofi reinforces collaboration with Stevenage Bioscience Catalyst with partnering office

April 13, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, Stevenage Bioscience Catalyst, academia, industry, partnership, pharma, stevenage

Sanofi has reinforced its collaboration with Stevenage Bioscience Catalyst with the opening of a new partnering office. This office will …

pharma manufacturing

‘Rejuvenated’ pharma manufacturing set for 2016 comeback

January 4, 2016
Manufacturing and Production, Sales and Marketing Employment, industry, manufacturing, patent cliff, pharma, production

The pharma industry has been singled out for its strong performance in 2015, in a report which says manufacturing in …


Pharma industry to deliver strong growth – despite price pressure

September 7, 2015
Sales and Marketing Moody's, financial ratings, industry, industry growth, pharma, pharma industry

The global pharma industry will buck the trend of growing pricing pressure and deliver strong growth in profits, according to a …

LaMattina image

John LaMattina: Pharma’s reputation continues to suffer – what can be done to fix it?

February 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, John LaMattina, industry, transparency

You don’t have too look far to find unflattering articles about the pharmaceutical industry. What was previously the domain of …

China pharma image

The future is bright – but don’t rely on emerging markets

November 16, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, emerging markets, industry, pwC

The pharma industry could be “on the cusp of a golden era” of renewed productivity and earnings – but only …

Changing business models top pharma concerns

July 16, 2010
Sales and Marketing Cegedim, industry, survey

The changing face of pharma business models is the main thing keeping US executives awake at night, according to a …

Blog footer

Digital Pharma: Social media an ‘enigma’ for pharma

July 15, 2010
Medical Communications Cegedim, Digital Pharma blog, digital pharma, industry, social media

The vast majority of pharma companies now use social media in one form or another, but it is unclear how …

No sign of revival in R&D productivity

June 30, 2010
Research and Development drug development, industry, research

New data on the performance of the pharmaceutical industry shows efforts to raise productivity have not yet made an impact. …

Andrew Witty

Let’s avoid further stand-offs, says Witty

June 22, 2010
Research and Development, Sales and Marketing EFPIA, Greece, industry, pricing

Pharma will need to find new ways of working with European governments in order to avoid further crises as witnessed …

R&D: a new world order

June 16, 2010
Manufacturing and Production, Research and Development industry, job cuts, research, research and development

Big pharma is today demolishing the in-house drug discovery and research structures built up over the last decade, and is …

Spain to cut prescription drug prices

May 19, 2010
Sales and Marketing Spain, industry, prices

The Spanish government will cut the prices of patented prescription drugs from 1 August in a bid to save 1.3 …

Greece’s crisis could hit European prices

May 6, 2010
Sales and Marketing Greece, industry, parallel trade, prices

GlaxoSmithKline’s chief executive Andrew Witty has warned that the economic crisis in Greece could have a knock-on effect across Europe, …

Brennan rejects generics diversification model

February 11, 2010
Sales and Marketing AstraZeneca, biosimilars, em, generics, industry

AstraZeneca’s chief executive David Brennan has rejected the strategy of diversification into generics and biosimilars being pursued by many of …

Latest content